首页> 外文期刊>Palliative medicine >A brief, patient- and proxy-reported outcome measure in advanced illness: Validity, reliability and responsiveness of the Integrated Palliative care Outcome Scale (IPOS)
【24h】

A brief, patient- and proxy-reported outcome measure in advanced illness: Validity, reliability and responsiveness of the Integrated Palliative care Outcome Scale (IPOS)

机译:先进疾病的简要介绍,患者和代理人报告的结果:综合姑息治疗结果规模的有效性,可靠性和响应性(IPO)

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Few measures capture the complex symptoms and concerns of those receiving palliative care. Aim: To validate the Integrated Palliative care Outcome Scale, a measure underpinned by extensive psychometric development, by evaluating its validity, reliability and responsiveness to change. Design: Concurrent, cross-cultural validation study of the Integrated Palliative care Outcome Scale - both (1) patient self-report and (2) staff proxy-report versions. We tested construct validity (factor analysis, known-group comparisons, and correlational analysis), reliability (internal consistency, agreement, and test-retest reliability), and responsiveness (through longitudinal evaluation of change). Setting/participants: In all, 376 adults receiving palliative care, and 161 clinicians, from a range of settings in the United Kingdom and Germany Results: We confirm a three-factor structure (Physical Symptoms, Emotional Symptoms and Communication/Practical Issues). Integrated Palliative care Outcome Scale shows strong ability to distinguish between clinically relevant groups; total Integrated Palliative care Outcome Scale and Integrated Palliative care Outcome Scale subscale scores were higher - reflecting more problems - in those patients with 'unstable' or 'deteriorating' versus 'stable' Phase of Illness (F = 15.1, p 0.60). Longitudinal validity in form of responsiveness to change is good. Conclusion: The Integrated Palliative care Outcome Scale is a valid and reliable outcome measure, both in patient self-report and staff proxy-report versions. It can assess and monitor symptoms and concerns in advanced illness, determine the impact of healthcare interventions, and demonstrate quality of care. This represents a major step forward internationally for palliative care outcome measurement.
机译:背景:少数措施捕获接受姑息治疗的复杂症状和担忧。目的:为了验证综合姑息治疗结果规模,通过评估其有效性,可靠性和响应性来改变,通过广泛的心理学发展衡量。设计:综合姑息治疗结果规模并发,跨文化验证研究 - 两(1)患者自我报告和(2)员工代理报告版本。我们测试了构建有效性(因子分析,已知的群体比较和相关分析),可靠性(内部一致性,协议和测试 - 重新测试)和响应性(通过变化纵向评估)。设定/参与者:在所有,376名成人接受姑息治疗和161名临床医生,来自英国和德国的一系列环境:我们确认了三因素结构(物理症状,情绪症状和沟通/实际问题)。综合姑息治疗结果规模表明了区分临床相关群体的强能力;总综合姑息治疗结果规模和综合姑息治疗结果规模额卡分数较高 - 反映了更多问题 - 在那些“不稳定”或“恶化”与“稳定”疾病的患者(F = 15.1,P 0.60)中的患者中的更多问题(F = 15.1,P 0.60)。纵向有效性以响应性的变化是好的。结论:综合姑息治疗结果规模是患者自我报告和员工代理报告版本的有效可靠的结果措施。它可以评估和监测晚期疾病的症状和疑虑,确定医疗保健干预的影响,并展示护理的质量。这代表了对姑息治疗结果测量的国际上向前迈出的重要一步。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号